Morgan Stanley’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q4
Sell
-74,823
Closed -$1.41M 6958
2019
Q3
$1.41M Sell
74,823
-746,073
-91% -$14.1M ﹤0.01% 4074
2019
Q2
$9.66M Sell
820,896
-12,290
-1% -$145K ﹤0.01% 2199
2019
Q1
$11.4M Sell
833,186
-125,334
-13% -$1.71M ﹤0.01% 1916
2018
Q4
$9.83M Sell
958,520
-171,516
-15% -$1.76M ﹤0.01% 2155
2018
Q3
$18.8M Sell
1,130,036
-453,624
-29% -$7.55M ﹤0.01% 1744
2018
Q2
$25M Buy
1,583,660
+387,037
+32% +$6.11M 0.01% 1439
2018
Q1
$15.2M Buy
1,196,623
+39,786
+3% +$505K ﹤0.01% 1937
2017
Q4
$13.2M Buy
1,156,837
+370,768
+47% +$4.25M ﹤0.01% 2107
2017
Q3
$9.63M Buy
786,069
+51,490
+7% +$631K ﹤0.01% 2321
2017
Q2
$8.41M Buy
734,579
+479,574
+188% +$5.49M ﹤0.01% 2339
2017
Q1
$5.31M Sell
255,005
-65,290
-20% -$1.36M ﹤0.01% 2807
2016
Q4
$6.66M Buy
320,295
+217,083
+210% +$4.51M ﹤0.01% 2693
2016
Q3
$3.38M Buy
103,212
+92,393
+854% +$3.03M ﹤0.01% 3048
2016
Q2
$270K Buy
10,819
+1,597
+17% +$39.9K ﹤0.01% 4787
2016
Q1
$226K Buy
9,222
+2,758
+43% +$67.6K ﹤0.01% 4904
2015
Q4
$214K Sell
6,464
-225,808
-97% -$7.48M ﹤0.01% 5053
2015
Q3
$7.61M Sell
232,272
-26,652
-10% -$873K ﹤0.01% 2239
2015
Q2
$13.7M Buy
258,924
+159,189
+160% +$8.43M ﹤0.01% 1814
2015
Q1
$2.88M Buy
99,735
+91,959
+1,183% +$2.65M ﹤0.01% 3237
2014
Q4
$226K Buy
7,776
+6,561
+540% +$191K ﹤0.01% 5180
2014
Q3
$15K Sell
1,215
-78,104
-98% -$964K ﹤0.01% 6097
2014
Q2
$1.59M Buy
+79,319
New +$1.59M ﹤0.01% 3673